The expanding role of mTOR in cancer cell growth and proliferation

Area of Science:

• Biochemistry and molecular biology
• Cellular signaling pathways
• Disease mechanisms

Background:

• The mechanistic/mammalian target of rapamycin (mTOR) is a key protein kinase controlling cell growth and proliferation.
• mTOR signaling is dysregulated in various pathologies, including cancer, obesity, type 2 diabetes, and neurodegeneration.
• mTOR complex 1 (mTORC1) regulates anabolic processes, including protein, lipid, and nucleic acid biosynthesis, via substrates like 4E-BPs and S6Ks.

Purpose of the Study:

• To elucidate the signaling pathways upstream and downstream of mTORC1.
• To examine the relevance of these pathways in human diseases.
• To review pharmacological strategies targeting mTOR for cancer treatment.

Main Methods:

• Review of existing literature on mTOR signaling pathways.
• Analysis of mTORC1 substrates and their roles in cellular processes.
• Exploration of therapeutic interventions targeting the mTOR pathway.

Main Results:

• Detailed examination of upstream and downstream signaling networks of mTORC1.
• Established links between mTOR dysregulation and the pathogenesis of major human diseases.
• Identified pharmacological agents targeting mTOR with potential in cancer therapy.

Conclusions:

• The mTOR pathway is a critical regulator of cell growth with significant implications in human diseases.
• Understanding mTOR signaling is crucial for developing targeted therapies, particularly for cancer.
• Pharmacological targeting of mTOR offers promising therapeutic avenues for various pathological conditions.